The IRIS Academic Research Group was founded by some of the world’s leading researchers and academic institutions and launched in June 2021 at the inaugural Global Vaccine Confidence Summit as part of the UK government’s G7 Presidency.
Overview Various efforts have been made to understand the spectrum of determinants of health outside of traditional clinical and public health frameworks.
Working through the spring of 2021, the CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation analysed the diverse forms of vaccine hesitancy in the United States and their links to international phenomena.
This initiative was inspired by the need for effective communication to prepare a ‘vaccine literate’ public and persuade policymakers to trust the science and embrace new vaccines for COVID-19 as they become available.
Overview This research, conducted in partnership with the Wellcome Trust, the UK Foreign, Commonwealth and Development Office and the Oswaldo Cruz…
EBODAC (Ebola Vaccine Deployment, Acceptance and Compliance) was set up to develop strategies and tools to encourage acceptance and uptake of new Ebola vaccines in the context of clinical trials.
LNCT is a platform dedicated to supporting countries as they transition away from Gavi support to full domestic financing of their national immunisation programs.
Many newer vaccines are not centrally funded in China, and therefore people pay for them out-of-pocket. China is investigating whether to increase the range of vaccines that are fully funded by the central government.
Maternal vaccination offers the potential to tackle the sustainable development goal 3 (SDG3) to reduce neonatal and maternal vaccination globally.
The Vaccine Confidence Project™ is a WHO Centre of Excellence on addressing Vaccine Hesitancy, and is engaged in many strands of research pertaining to vaccine hesitancy.